[Cancer of the upper aerodigestive tract. Global study of 2418 cases].
The authors present the general results of a retrospective study on 2418 patients treated between 1976 and 1980. Primaries were located on buccopharynx in 51% of cases, pharyngolarynx in 45% and nasopharynx or nasal and paranasal cavities in 4%. Two out of 3 tumours were classified T3 T4 (UICC 1979) and 1 out of 2 patients presented with palpable cervical lymph nodes. Taking into account persistent diseases and recurrences, failure at primary sites occurred in 40% of patients, in the neck in 20%, distant metastases in 10%. Synchronous and/or metachronous cancers were observed in 1 out of 3 patients. Actuarial survival rates were 2/3 at 1 year, 1/3 at 3 years, 1/4 at 5 years and 1/7 at 8 years. Endolaryngeal tumours had the best prognosis while hypopharyngeal tumours had the worst prognosis.
Lefebvre
J L
JL
Service d'ORL et de carcinologie cervico-maxillo-faciale, centre Oscar-Lambret, Lille, France.
Cambier
L
L
Coche-Dequeant
B
B
Joveniaux
A
A
Lesoin-Montaigne
A
A
Buisset
E
E
Prevost
B
B
Caty
A
A
Castelain
B
B
Vankemmel
B
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006258:Head and Neck Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D009303:Nasopharyngeal Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D010255:Paranasal Sinus Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D010610:Pharyngeal Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies
Les cancers des voies aérodigestives supérieures. Etude globale de 2418 dossiers.